Enhancing effects of long-term elevated glucose and palmitate on stored and secreted proinsulin-to-insulin ratios in human pancreatic islets

Diabetes

Volumn 48, Issue 7, 1999, Pages 1409-1414

  Björklund, Anneli ^a,c   Grill, Valdemar ^a,b  

^a KAROLINSKA INSTITUTE   (Sweden)

^b NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

DIAZOXIDE; GLUCOSE; INSULIN; PALMITIC ACID; PROINSULIN;

ADULT; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; HUMAN; HUMAN TISSUE; HYPERGLYCEMIA; HYPERLIPIDEMIA; INSULIN RELEASE; PANCREAS ISLET; PRIORITY JOURNAL;

ADULT; CELLS, CULTURED; CULTURE MEDIA; DIABETES MELLITUS, TYPE 2; DIAZOXIDE; GLUCOSE; HUMANS; INSULIN; ISLETS OF LANGERHANS; MIDDLE AGED; PALMITATES; PROINSULIN; SPECIMEN HANDLING; TIME FACTORS;

EID: 0040503709     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.48.7.1409     Document Type: Article

References (31)

1. Mako ME, Starr JI, Rubenstein AH: Circulating proinsulin in patients with maturity onset diabetes. Am J Med 63:865-869, 1977
2. Ward WK, LaCava EC, Paquette TL, Beard JC, Wallum BJ, Porte DJ: Disproportionate elevation of immunoreactive proinsulin in type 2 (non-insulin-dependent) diabetes mellitus and in experimental insulin resistance. Diabetologia 30:698-702, 1987
3. Yoshioka N, Kuzuya T, Matsuda A, Taniguchi M, Iwamoto Y: Serum proinsulin levels at fasting and after oral glucose load in patients with type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 31:355-360, 1988
4. Temple RC, Carrington CA, Luzio SD, Owens DR, Schneider AE, Sobey WJ, Hales CN: Insulin deficiency in non-insulin-dependent diabetes. Lancet 1: 293-295, 1989
5. Yoshioka N, Kuzuya T, Matsuda A, Iwamoto Y: Effects of dietary treatment on serum insulin and proinsulin response in newly diagnosed NIDDM. Diabetes 38:262-266, 1989
6. Davies MJ, Metcalfe J, Day JL, Grenfell A, Hales CN, Gray IP: Improved beta cell function, with reduction in secretion of intact and 32/33 split proinsulin, after dietary intervention in subjects with type 2 diabetes mellitus. Diabet Med 11:71-78, 1994
7. Clausson P, Alvarsson M, Grill V: Enhancement of β-cell secretion by blood glucose normalization relates to fasting C-peptides levels. J Intern Med 241: 493-500, 1997
8. Rachman J, Levy JC, Barrow BA, Manley SE, Turner RC: Relative hyperproinsulinemia of NIDDM persists despite the reduction of hyperglycemia with insulin or sulfonylurea therapy. Diabetes 46:1557-1562, 1997
9. Leahy JL: Increased proinsulin/insulin ratio in pancreas extracts of hyperglycemic rats. Diabetes 42:22-27, 1993
10. Alacrón C, Leahy JL, Schuppin GT, Rhodes CJ: Increased secretory demand rather than a defect in the proinsulin conversion mechanism causes hyperproinsulinemia in a glucose-infusion rat model of non-insulin-dependent diabetes mellitus. J Clin Invest 95:1032-1039, 1995
11. Gadot M, Ariav Y, Cerasi E, Kaiser N, Gross DJ: Hyperproinsulinemia in the diabetic Psammomys obesus is a result of increased secretory demand on the β-cell. Endocrinology 136:4218-4223, 1995
12. Leahy JL, Halban PA, Weir GC: Relative hypersecretion of proinsulin in a rat model of NIDDM. Diabetes 40:985-989, 1991
13. Gadot M, Leibowitz G, Shafrir E, Cerasi E, Gross DJ, Kaiser N: Hyperproinsulinemia and insulin deficiency in the diabetic Psammomys obesus. Endocrinology 135:610-616, 1994
14. Bertuzzi F, Saccomanno K, Socci C, Davalli AM, Taglietti MV, Berra C, Dalcin E, Monti LD, Pozza G, Pontiroli AE: Long-term in vitro exposure to high glucose increases proinsulin-like-molecules release by isolated human islets. J Endocrinol 158:205-211, 1998
15. Sako Y, Grill V: A 48 h lipid infusion in the rat time-dependently inhibits glucose-induced insulin secretion and β-cell oxidation through a process likely coupled to fatty acid oxidation. Endocrinology 127:1580-1589, 1990
16. Zhou Y, Grill V: Long term exposure of rat pancreatic islets to fatty acids inhibits glucose-induced insulin secretion and biosynthesis through a glucose fatty acid cycle. J Clin Invest 93:870-876, 1994
17. + channel in the mouse pancreatic β-cells. Pfteugers Arch 407:493-499, 1986
18. Björklund A, Grill V: Glucose and palmitate enhance proinsulin/insulin release from human islets through an insulin depletion defect (Abstract). Diabetologia 41 (Suppl. 1):76A, 1998
19. Eizirik DL, Korbutt GS, Hellerström C: Prolonged exposure of human pancreatic islets to high glucose concentrations in vitro impairs the β-cell function. J Clin Invest 90:1263-1268, 1992
20. Pipeleers DG, in't Veld P, Maes E, Shuit F, Gepts W: A new in vitro model for the study of pancreatic A and B cells. Endocrinology 117:806-816, 1985
21. Ling Z, Pipeleers DG: Prolonged exposure of human β cells to elevated glucose levels results in sustained cellular activation leading to loss of glucose regulation. J Clin Invest 98:2805-2812, 1996
22. Umbreit WW, Burns RH, Stauffer JF: In Manometric Techniques. Minneapolis, Burgess, 1957, p. 149-150
23. Bowsher RR, Wolney JD, Frank BH: A rapid and sensitive radioimmunoassay for the measurement of proinsulin in human serum. Diabetes 41:1084-1090, 1992
24. Kahn SE, Halban PA: Release of incompletely processed proinsulin is the cause of the disproportionate proinsulinemia of NIDDM. Diabetes 46:1725-1732, 1997
25. Sako Y, Eizirik DL, Grill V: Impact of uncoupling glucose stimulus from secretion on β-cell release and biosynthesis. Am J Physiol 262:E150-E154, 1992
26. Björk E, Kämpe O, Andersson A, Karlsson FA: Expression of the 64 kDa/glutamatic acid decarboxylase rat islet cell autoantigen is influenced by the rate of insulin secretion. Diabetologia 32:490-493, 1992
27. Nagamatsu S, Grodsky GM: Glucose-regulated proinsulin processing in isolated islets from rat pancreas. Diabetes 37:1426-1431, 1988
28. Zhou Y, Grill V: Long term exposure to fatty acids and ketones inhibits β-cell functions in human pancreatic islets of Langerhans. J Clin Endocrinol Metab 80:1584-1590, 1995
29. Bollheimer C, Skelly R, Chester M, McGarry D, Rhodes C: Chronic exposure to free fatty acid reduces pancreatic beta cell insulin content by increasing basal insulin secretion that is not compensated for by a corresponding increase in proinsulin biosynthesis translation. J Clin Invest 101:1094-1101, 1998
30. Furukawa H, Caroll R, Steiner D: Long term elevation of free fatty acids leads to delayed processing of proinsulin and prohormone convertases 2 and 3 in the pancreatic beta cell line MIN 6 (Abstract). Diabetes 47:262A, 1998
31. Sizonenko S, Irminger J, Buhler L, Deng S, Moul P, Halban P: Kinetics of proinsulin conversion in human islets. Diabetes 42:933-936, 1993